Scientist

Zymergen is a biotechnology company that specializes in machine learning, big data, and artificial intelligence.

Zymergen is a biotechnology company that specializes in the fields of machine learning, big data, and artificial intelligence. The company partner with nature to create materials and products across industries from agriculture to electronics, consumer care to pharmaceuticals, and more.

Zymergen

Scientist, High Content Imaging

Zero Acre Farms is a food company that aims to end the food industry's dependence on destructive vegetable oils.

Zero Acre Farms is a food company that aims to end the food industry's dependence on destructive vegetable oils. It provides an improved alternative, produced by microorganisms and fermentation.

Zero Acre Farms

Fermentation Scientist

Visolis, a bioengineering company, develops carbon-negative and sustainable chemicals.

Visolis, a bioengineering company, develops carbon-negative and sustainable chemicals. Its systems approach integrates innovations in synthetic biology, chemical catalysis, and process scale-up to enable new bio-based manufacturing platforms. Visolis' bio-based process helps in achieving true carbon negative chemical synthesis. It began operation in 2012, with its headquarters in Berkeley in California.

Visolis

Scientist, Bioengineering

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Vigil will use the Series A funds to progress its lead pipeline candidate, a monoclonal antibody TREM2 agonist, through Phase 1 studies, advance their small molecule TREM2 agonist to IND, as well as pursue additional assets to grow the pipeline and increase the body of data supporting microglia biology as an important therapeutic pathway.

Vigil Neuroscience

Scientist, Discovery Biology (Contract)

ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.

ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts. It discovers and develops innovative therapeutics that can utilize a family of endogenous enzymes called adenosine deaminase acting on RNA (ADAR) to precisely target and correct single point mutations on an mRNA, thus the production of desired and functional protein is restored. The company was founded in 2019 and is headquartered in San Diego, California.

Location

Company Stage

Age of Data

Experience

Industry

Company

Scientist

Zymergen

N/A

N/A

Scientist, High Content Imaging

N/A

N/A

Scientist, High Content Imaging

N/A

N/A

Zero Acre Farms

N/A

N/A

Fermentation Scientist

N/A

N/A

Visolis

N/A

N/A

Scientist, Bioengineering

N/A

N/A

Vigil Neuroscience

N/A

N/A

Scientist, Discovery Biology (Contract)

N/A

N/A

ADARx Pharmaceuticals

N/A

N/A

Scientist

N/A

N/A